Submit Deal

Submit Deal

Cover Image Rebecca Luse

Rebecca Luse

Principal at DEEP TRACK CAPITAL

Investor

Deal Bio

Total Deals5

Valued Deals5

Total Value£ 576 M

Avg. Deal Size£ 115 M

Market Context

Sort

07 Dec 2022|United States|Biotechnology

Target: APOGEE THERAPEUTICS

Bidder: PERCEPTIVE ADVISORS LLC

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 122 M

Value

07 Sep 2023|United States|Biotechnology

Target: MARIANA ONCOLOGY

Bidder: DEEP TRACK CAPITAL

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 139 M

Value

10 Apr 2024|United States|Pharmaceuticals

Target: TORL BIOTHERAPEUTICS LLC

Bidder: DEEP TRACK CAPITAL

4 Service Providers

1 Target | 3 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 124 M

Value

12 Aug 2024|United States|Biotechnology

Target: HALDA THERAPEUTICS

Bidder: DEEP TRACK CAPITAL

7 Service Providers

2 Target | 5 Bidder

8 Dealmakers

4 Target | 4 Bidder

£ 99 M

Value

03 Dec 2024|United States|Biotechnology

Target: MAZE THERAPEUTICS

Bidder: JANUS HENDERSON INVESTORS

6 Service Providers

3 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 90 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite